MCMV induces neointima in IFN-gammaR-/- mice: intimal cell apoptosis and persistent proliferation of myofibroblasts

D Hamamdzic1, R A Harley, D Hazen-Martin

  • 1Department of Microbiology, Medical University of South Carolina, Charleston 29425, USA. hamamdd@musc.edu

Abstract

Insights

Cytomegalovirus (CMV) infection in mice can cause intimal injury and neointima formation, mimicking autoimmune vasculopathies. This process requires both infection and immunosuppression, highlighting a potential link between CMV and vascular disease.

Area of Science:

  • Vascular Biology
  • Immunology
  • Virology

Background:

  • Cytomegalovirus (CMV) infections are associated with vasculopathies such as atherosclerosis and Scleroderma.
  • CMV infects vascular endothelium, leading to viral shedding and latency.

Purpose of the Study:

  • To investigate the role of murine cytomegalovirus (MCMV) infection in neointima formation using a mouse model of arteritis.
  • To determine the conditions under which MCMV infection leads to vascular pathology.

Main Methods:

  • Utilized a murine model of arteritis triggered by MCMV infection.
  • Compared neointima formation in immunocompetent mice, immunocompetent mice with irradiation, IFN-gammaR-/- mice, and IFN-gammaR-/- mice with irradiation.
  • Analyzed histopathology, immunohistochemistry, growth factor expression, and cell proliferation/apoptosis in affected tissues.

Main Results:

  • MCMV infection in immunocompetent mice caused transient perivascular inflammation but no intimal pathology.
  • Combined MCMV infection and whole-body irradiation in immunocompetent mice led to mild to moderate intimal lesions.
  • IFN-gammaR-/- mice infected with MCMV and subjected to irradiation developed significant neointima, characterized by myofibroblasts, growth factor up-regulation, and apoptosis.

Conclusions:

  • CMV infection, in conjunction with immunosuppression, can induce intimal injury and neointima formation.
  • The findings suggest a potential mechanism by which CMV contributes to autoimmune vasculopathies.